• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP G4 CLIP DELIVERY SYSTEM; MITRAL VALVE REPAIR DEVICES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP G4 CLIP DELIVERY SYSTEM; MITRAL VALVE REPAIR DEVICES Back to Search Results
Catalog Number CDS0702-XTW
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Enzyme Elevation (1838); Thrombosis/Thrombus (4440)
Event Date 02/24/2021
Event Type  Injury  
Manufacturer Narrative
The device is not returning.The clip remains in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This is filed to conservatively report thrombus.It was reported this was a mitraclip procedure to treat grade 4 functional mitral regurgitation (mr).When attempting the transseptal puncture, prior to inserting the steerable guide catheter (sgc), thrombus was observed on the transseptal needle.The transseptal puncture was successful, the sgc was inserted and thrombus was aspirated over the sgc.Thereafter, the sgc was removed and flushed with saline and the sgc and mitraclip delivery system were inserted, and st-elevation was observed.Heparin was given and the st-elevation disappeared.The mitraclip procedure was continued, one clip was implanted, reducing mr to <1.It is unknown if the mitraclip devices caused or contributed to the thrombus and st elevation.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.The reported patient effects of cardiac enzyme elevation and thrombosis as listed in the mitraclip g4 system instructions for use (ifu), are known possible complications associated with mitraclip procedures.Based on this information, a cause for the reported thrombus could not be determined.The reported cardiac enzyme elevation was a result of the reported thrombus.The reported unexpected medical intervention and medication required were a result of case specific circumstances as the thrombus had to be aspirated and heparin was administered.There is no indication of a product issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP G4 CLIP DELIVERY SYSTEM
Type of Device
MITRAL VALVE REPAIR DEVICES
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key11510246
MDR Text Key240597017
Report Number2024168-2021-02137
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/04/2021
Device Catalogue NumberCDS0702-XTW
Device Lot Number00902U448
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/24/2021
Initial Date FDA Received03/17/2021
Supplement Dates Manufacturer Received05/11/2021
Supplement Dates FDA Received05/21/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
STEERABLE GUIDE CATHETER; STEERABLE GUIDE CATHETER
Patient Outcome(s) Required Intervention;
-
-